PTEN and breast carcinoma: As expected, TNBC patients carrying mutations in TP53 (84%), PTEN (11%) and BRCA1/2 (8% and 7%, respectively) were relatively frequent among breast cancer (BC) patients in the PanCancer Atlas [39] (Fig. 2A, Additional file 1: Fig. S1A).